VLA Comment: HPV does not cause cancer!
EXCERPTS: They raised troubling questions about some vaccine ingredients’ documented impact on reproduction, cited serious deficiencies (some would say criminal negligence) in preliminary vaccine trials and concluded that further research was “urgently required….for the purposes of population health and public vaccine confidence.”
Approximately 60% of women who did not receive the HPV vaccine had been pregnant at least once compared to just 35% of women who had had an HPV shot had ever conceived.
For married women, the gap was also about 25%: 75% who did not receive the shot were found to have conceived, while only 50% who received the vaccine had ever been pregnant.
“Results suggest that females who received the HPV shot were less likely to have ever been pregnant than women in the same age group who did not receive the shot,” the study says.
HPV vaccination is recommended for all girls age 11 to 12, with “catch-up” doses for girls and women from 13 to 26 who haven’t been vaccinated (there are no booster recommendation as of yet).[*]
At this time, protection against cervical intraepithelial neoplasia grade 2/3 (CIN 2/3) is 5 years for Gardasil and 8.4 years for Cervarix.[*]
If your daughter receives an HPV vaccine at the recommended age of 11, protection will have waned by age 16.
The data collected from the above agency confirms approximately 0.0% deaths from cervical cancer under age 20.[*]
What is “one less” then 0%?
Pfizer Vice President Dr. Peter Rost blows the whistle on ‘deadly’ vaccines.
Bombshell #3: Pregnancy Outcomes
According to the Gardasil 9 package insert, 1,028 women who were injected with Gardasil 9 became pregnant during the course of the clinical trials along with 991 women who had been injected with Gardasil. Overall, 14.1% of the Gardasil 9 women suffered adverse outcomes while 17.0% of the Gardasil women suffered the same fate. A total of 313 women either lost their babies to spontaneous abortion or late fetal death or gave birth to children with congenital anomalies. READ MORE…
|225 mcg||AAHS (aluminum adjuvant)||500 mcg|
|9.56 mcg||Sodium Chloride||9.56 mcg|
|.78 mcg||L-Histidine||.78 mcg|
|50 mcg||Polysorbate 80||50 mcg|
|35 mcg||Sodium Borate||35 mcg|
|<7 mcg||Yeast Protein||<7 mcg|
|20 mcg||HPV 6 L1 protein||30 mcg|
|40 mcg||HPV 11 L1 protein||40 mcg|
|40 mcg||HPV 16 L1 protein||60 mcg|
|20 mcg||HPV 18 L1 protein||40 mcg|
|HPV 31 L1 protein||20 mcg|
|HPV 33 L1 protein||20 mcg|
|HPV 45 L1 protein||20 mcg|
|HPV 52 L1 protein||20 mcg|
|HPV 58 L1 protein||20 mcg|
Infant Accidentally Vaccinated with Gardasil – Mother Blamed for Vaccine Injuries and Baby Medically Kidnapped
HPV Vaccine Injuries: “I Cannot Begin to Describe What it is Like to Watch your Daughter Live in Such Agony”
This article critically reviews HPV vaccine serious adverse events described in pre-licensure randomized trials and in post-marketing case series. HPV vaccine randomized trials were identified in PubMed. Safety data were extracted. Post-marketing case series describing HPV immunization adverse events were reviewed. Most HPV vaccine randomized trials did not use inert placebo in the control group. Two of the largest randomized trials found significantly more severe adverse events in the tested HPV vaccine arm of the study.
(9/2017)Guyana to Vaccinate Thousands of Girls with HPV vaccine
(10/2017) Jamaica urged to hold off on HPV vaccine
Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
Objectives. We sought to investigate roles that Merck & Co Inc played in state human papillomavirus (HPV) immunization policymaking, to elicit key stakeholders’ perceptions of the appropriateness of these activities, and to explore implications for relationships between health policymakers and industry.
Methods. We used a series of state case studies combining data from key informant interviews with analysis of media reports and archival materials. We interviewed 73 key informants in 6 states that were actively engaged in HPV vaccine policy deliberations.
Results. Merck promoted school-entry mandate legislation by serving as an information resource, lobbying legislators, drafting legislation, mobilizing female legislators and physician organizations, conducting consumer marketing campaigns, and filling gaps in access to the vaccine. Legislators relied heavily on Merck for scientific information. Most stakeholders found lobbying by vaccine manufacturers acceptable in principle, but perceived that Merck had acted too aggressively and nontransparently in this case.
Conclusions. Although policymakers acknowledge the utility of manufacturers’ involvement in vaccination policymaking, industry lobbying that is overly aggressive, not fully transparent, or not divorced from financial contributions to lawmakers risks undermining the prospects for legislation to foster uptake of new vaccines.
The panel consensus is that virtually all youngsters receive the HPV vaccine. The CDC and American Cancer Society say that there will be 12,000 cervical cancers diagnosed in the United States each year, among a population of 170 million women. The chances of my daughter being diagnosed in any given year are 12,000 out of 170 million, which works out to .007 percent. The odds of her not being diagnosed in any given year, by the same math, is 99.9929 percent.
Accordingly, the blanket claim that the vaccine has no serious adverse effects should be carefully revisited.ed 10 years later, were actually more likely to be infected with high risk, low risk, and all strains of HPV. The four vaccine strains were reduced- but other, possibly more pathogenic, HPV viruses moved in to fill the void.
The American Center for Cancer Research reported in 2015 that girls who received the four strain HPV shot, when assessA VAERS review of HPV vaccine reports shows
54,105 adverse reactions.
Among those, 2,227 are listed as “disabled,”
10,416 are listed as “did not recover,”
7,418 are listed as “serious,”
and 362 deaths have been reported.
VLA Comment: It is well known that the VAERS reporting is at a 1% level. Dr. Paul G. King discovered in his research on the flu vaccine concerning a CDC spontaneous abortion study that reported that there were approx. 900 fetal demise reported by Kaiser Permanente covering only the Northern California area. Dr. King compared that to the VAERS reporting which is required by law that the physicians report the associated vaccine adverse reaction. He found no reports to VAERS for the same time period. Can one conclude that if there were 900 reports (in No. California alone) that was not reported to VAERS that the 54,105 adverse reaction reports to VAERS are greatly underestimated?